Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 29, 2025
Relations between trajectories of weight loss and changes in psychological health over a period of 2 years following bariatric metabolic surgeryJohanna Eveliina Pyykkö, Nienke van Olst, Victor E A Gerdes, et al.
Obesity Surgery|April 24, 2023
Identifying Gut Microbiota associated with Gastrointestinal Symptoms upon Roux-en-Y Gastric BypassMadelief Wijdeveld, Nienke van Olst, Eduard W J van der Vossen, et al.
Trials|July 25, 2020
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial)Sylke Haal, Maimoena S S Guman, L Maurits de Brauw, et al.
The British Journal of Surgery|August 18, 2022
Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgerySylke Haal, Maimoena S S Guman, L Maurits de Brauw, et al.
Obesity Surgery|February 6, 2024
Variation in HbA1c in Patients with Obesity and type 2 Diabetes Mellitus 12 months after Laparoscopic One-Anastomosis Gastric Bypass and Laparoscopic Roux-en-Y Gastric Bypass: a Retrospective Matched Cohort StudyAnne-Sophie van Rijswijk, Abraham S Meijnikman, Sarah Mikdad, et al.
Gut Microbes|February 7, 2022
Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgeryTorsten P M Scheithauer, Mark Davids, Maaike Winkelmeijer, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|April 7, 2022
Factors associated with adherence to ursodeoxycholic acid or placebo in patients after bariatric surgeryMaimoena S S Guman, Sylke Haal, L Maurits de Brauw, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 4, 2017
Transhepatic bile acid kinetics in pigs and humansHannah M Eggink, F Samuel van Nierop, Marieke G Schooneman, et al.
Obesity Science & Practice|February 7, 2022
Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesityGuido J Bakker, Abraham S Meijnikman, Torsten P Scheithauer, et al.
Cell|November 8, 2018
Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1Ara Koh, Antonio Molinaro, Marcus Ståhlman, et al.
Pageof 4